Roche Diagnostics ramps up for double-digit growth in India

With India's in vitro diagnostic market expected to grow at a 13% rate over the next several years, Roche Diagnostics ($RHHBY) views business prospects there as an enormous growth opportunity, Lance Little, managing director for the company's Indian operations, told The Times of India. To boost business, Roche plans to provide training and engineering support to labs that choose to use the company's diagnostics products. Among the products Roche will focus on, according to the story: Screening tests to ensure safe blood transfusions and a high-risk HPV diagnostic test. Story

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.